Cytophage Technologies Ltd. Stock Price

TSXV:CYTO.H Community·CA$338.4k Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

CYTO.H Share Price Performance

CA$0.005

-0.20 (-97.56%)

CA$0.005

-0.20 (-97.56%)

CA$0.005

Thu, 11 Jun 26

Share Pricen/a

CYTO.H Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks

0 Rewards

View Full Analysis

Cytophage Technologies Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: -0.061
: 0%
: 0%
: 0%

View Full Analysis

About CYTO.H

Founded: n/a
Employees: n/a
CEO: Steven Theriault
WebsiteView website: cytophage.com

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops water-soluble solution for livestock producers under the FarmPhage name; poultry health products under the AviPhage name; food safety products under the PhageFend name; and bovine mastitis products under the BoviPhage name. Cytophage Technologies Ltd. is headquartered in Oak Bluff, Canada.